Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-01-17 @ 12:16 AM
Study NCT ID:
NCT01044459
Status:
COMPLETED
Last Update Posted:
2017-04-20
First Post:
2010-01-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Obstructive Pulmonary Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Chronic Obstructive Pulmonary Disease | View |
| None | COPD | View |
| None | Chronic Bronchitis | View |
| None | Emphysema | View |
| None | Airflow Obstruction, Chronic | View |
| None | Chronic Airflow Obstruction | View |
| None | Chronic Obstructive Airway Disease | View |
| None | Chronic Obstructive Lung Disease | View |